StockWatch
·

Apex Frozen Foods Ltd Q2 FY27 Results

APEXQ2 FY27 Results
Filing
Result:Steady· Market: Down#One-off hit#Base effect#Margin squeeze#Debt reduction

Beat/Miss: Miss

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue273.716.7%14.8%
Total Income278.097.2%13.7%
Expenditure264.9714.8%14.4%
PBT3.7586.9%76.0%
Net Profit2.1290.2%82.2%
OPM1.45%10.34pp4.39pp
NPM0.76%7.59pp4.09pp
EPS0.6890.2%82.1%
View full financials

Agri/processing core-margin lens: adjusted PAT rose ~23% YoY on lower finance costs, but EBITDA margin compressed to ~6.5% from ~7.4% (missing management's stable-margin guidance) and revenue growth was middling, so the reported headline loss-looking print is really an in-line, guidance-missed quarter once the ADD provision one-off is stripped out.

Q2 FY-2027 RESULTS · ARDEE

Ardee Indu stries Q2 FY27: PAT falls 38% YoY as margins compress despite 34% revenue growth

PAT -37.79% YoY · revenue +33.5% · margins compressing

12 Nov 2026 · 3 min read
Revenue

₹324.79 Cr

+33.5% YoY

PAT (standalone)

₹18.06 Cr

-37.79% YoY

Net margin

5.54%

EPS

₹0.57

Ardee Industries' standalone revenue for Q2 FY27 (quarter ended September 30, 2026) came in at ₹324.79 Cr, up 33.5% year-on-year from ₹243.29 Cr but down 4.1% sequentially from ₹338.81 Cr. Standalone PAT fell 37.8% YoY to ₹18.06 Cr (from ₹29.03 Cr) and was down 9.3% QoQ (from ₹19.90 Cr), with basic EPS at ₹0.57 against ₹1.20 a year ago and ₹0.78 last quarter — the EPS decline is sharper than the profit decline because the fresh IPO issuance of 60.38 million shares (listed on NSE/BSE August 12, 2026) diluted the per-share base mid-quarter. There are no exceptional items on the face of the statement, so this is a genuine operating-margin story rather than a one-off.

The scoreboard

Q2 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹324.79 Cr-4.1%—
Expenses₹301.81 Cr-3.4%—
PAT₹18.06 Cr-9.27%-37.79%
Net margin5.54%-0.3pp—
EPS₹0.57-26.9%—

No year-ago quarter on record — YoY cells may be blank.

The profit decline is almost entirely a margin story: operating margin (EBITDA/revenue) compressed to roughly 8.6% in Q2 from about 19.4% a year ago and 9.9% last quarter, while net margin fell to 5.56% from 11.93% YoY. The squeeze traces mainly to the cost-of-materials line, which rose to 81.4% of revenue from 78.0% a year ago, compounded by an inventory drawdown this quarter (adding ₹5.16 Cr to costs) versus an inventory build a year ago (which had reduced costs by ₹24.31 Cr) — roughly an 11-12 percentage-point swing on its own. Partly offsetting this, finance costs fell 66% YoY to ₹2.19 Cr (from ₹6.48 Cr) on debt paydown funded by IPO proceeds.

₹
39.5646.5653.5760.5867.584508-1309-0309-2510-1911-0911-12Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹45, down 6.7% over the past month of trading.

What management guided (1 FY-2027 call)
FY27 revenue growth 10-20% volume-driven; EBITDA margins ~10% (vs 12.6% FY26); optimum 70-75% capacity utilization deferred to FY28; ₹400+ Cr gross working capital requirement targeted.

— This quarter: met

Street comparison isn't meaningful here — Ardee has no active sell-side analyst coverage, so there is no consensus estimate to benchmark against. Against management's own guidance from the Q1 FY27 concall, revenue is running well ahead of plan: H1 FY27 revenue of ₹663.60 Cr is up 34.4% YoY, above the top end of the 10-20% volume-led growth management guided for the full year. Margins, however, are tracking the guided compression rather than beating it — H1 OPM of ~9.3% sits close to management's ~10% target (itself a step down from FY26's 12.6%), and Q2 OPM of 8.6% is a touch below even that lowered bar, with the 70-75% capacity-utilisation target still deferred to FY28 as flagged last quarter. The quarter's dominant corporate event was the IPO itself: Ardee raised net proceeds of ₹286.27 Cr (gross ₹319.99 Cr) via a fresh issue of 60.38 million shares plus an offer for sale of 19.98 million shares; ₹20 Cr has already gone to debt prepayment and ₹199.47 Cr of the ₹220 Cr earmarked for incremental working capital is utilised, while current borrowings fell to ₹34.82 Cr from ₹167.84 Cr at FY26-end. No separate management press release accompanied this filing beyond the standard board-outcome letter and notes to the financial statements.

  • W1

    Operating margin trajectory toward management's ~10% FY27 EBITDA margin guidance (H1 at ~9.3%, Q2 at ~8.6%), with 70-75% capacity utilisation still deferred to FY28

  • W2

    Deployment of the ₹66.98 Cr of still-unutilised net IPO proceeds (₹20.53 Cr working capital + ₹46.17 Cr general corporate, as of Sep 30, 2026)

  • W3

    Whether revenue growth holds above the 10-20% FY27 guided band given this quarter's 4.1% QoQ moderation (H1 YoY growth at +34.4%)

Informational and educational content only. Not investment advice.